SWIDRO gel de consoude tb 100 g

7680569410224 CH-56941 M02AX10 07.10.4.
SWIDRO gel de consoude tb 100 g
SWIDRO gel de consoude tb 100 g
SWIDRO gel de consoude tb 100 g
1 / 3
google

Details

Product number
5694101
CPT
-
Packaging group
100
Unit
g
Composition
symphyti radicis recentis extractum ethanolicum liquidum (Symphytum officinale L., radix) 350 mg DER: 1:3-4 Auszugsmittel ethanolum 52% (m/m), hyperici herbae recentis extractum ethanolicum liquidum (Hypericum perforatum L., herba) 50 mg DER: 1:1.5-2.5 Auszugsmittel ethanolum 86 % (m/m), calendulae herbae recentis extractum ethanolicum liquidum (Calendula officinalis L., herba) 50 mg DER: 1:1.5-2.5 Auszugsmittel ethanolum 86 % (m/m), echinaceae purpureae herbae recentis extractum ethanolicum liquidum (Echinacea purpurea L., herba) 25 mg DER: 1:1.5-2.5 Auszugsmittel ethanolum 86 % (m/m), menthae piperitae recentis extractum ethanolicum liquidum (Mentha x piperita L., herba) 25 mg DER: 1:1.5-2.5 Auszugsmittel ethanolum 86 % (m/m), ethanolum 96 per centum, aqua purificata, carbomerum 980, diisopropanolaminum, ad gelatum 1 g, corresp. ethanolum 330 mg.

Articles (1)

Swidro Wallwurz-Gel, Gel
Gel
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/06/2022
Patient information leaflet
Français
15/06/2022
Patient information leaflet
Italien
15/06/2022

Detailed composition

Substance Quantity Type Category
(N/A)
350.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
330.0 MG Substance HBESI

Authorization holder

Alpinamed AG

9325 Roggwil TG

Authorization information

Swissmedic authorization number
56941
Drug name
Swidro Wallwurz-Gel, Gel
Galenic form
GELK
ATC Code
M02AX10
Authorization status
Z
Authorization category
Category C
Dispensation category
D
First authorization
27/04/2004
Authorization expiration date
31/12/9999
IT number
07.10.4.
Domain
Human medicine
Field of application
Bei stumpfen Verletzungen und zur unterstützenden Behandlung bei rheumatischen Beschwerden

Packaging details

Description (FR)
SWIDRO gel de consoude tb 100 g
Description (DE)
SWIDRO Wallwurz Gel Tb 100 g
Market launch
27/04/2004
Narcotic (BTM)
No

Other packaging sizes

SWIDRO gel de consoude tb 200 g
200 G
View